Trial Profile
AN OPEN LABEL PHASE 2A TRIAL ASSESSING THE CLINICAL EFFICACY AND SAFETY OF RO5459072 IN MODERATE TO SEVERE PSORIASIS
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Jun 2020
Price :
$35
*
At a glance
- Drugs Petesicatib (Primary)
- Indications Psoriasis
- Focus Therapeutic Use
- Sponsors Roche
- 11 Jun 2020 Status changed from recruiting to completed.
- 17 Nov 2018 New trial record